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Background: Patients with peripheral arterial disease (PAD) have been reported to have higher circulating levels of N terminal pro-B-type 
natriuretic peptide (NT-pro-BNP) than controls. We hypothesized that among patients with PAD, those with non-compressible (“stiff”) vessels have 
greater hemodynamic stress (as manifested by higher NT-pro-BNP levels) than in patients without “stiff” vessels.
Methods: We studied 620 PAD cases (68±10 y) identified in the non-invasive vascular laboratory as having an ankle-brachial index (ABI) <0.9 at 
rest or after exercise (n= 511) or ABI >1.4 (“stiff” vessels; n= 109). Controls (n=102; 64±10 y) were patients referred for cardiovascular screening 
who had no evidence of PAD. Serum NT-pro-BNP levels were measured by immunoassay. Multivariable regression analyses were used to identify 
independent predictors of NT-pro-BNP levels in PAD patients from among age, sex, conventional risk factors, history of coronary heart disease (CHD) 
or stroke, and serum creatinine. Next, we investigated, within the PAD group, whether NT pro-BNP levels differed between patients with “stiff” vessels 
and those without “stiff” vessels.
Results: Patients with PAD had significantly higher NT-pro-BNP levels (pg/mL) than controls [median (interquartiles) 176 (68, 543) vs. 47 (29, 84), 
P <0.001]. The difference remained significant (P <0.001) after adjustment for variables associated with higher NT-pro-BNP levels in PAD patients 
- greater age, hypertension, higher systolic BP, history of CHD or cerebrovascular disease, higher creatinine, lower total cholesterol, statin use, and 
diabetes. Within the PAD group, those with “stiff” vessels had significantly higher levels of NT-pro-BNP (pg/mL) than those with ABI <0.9 [533 (140, 
1456) vs. 149 (64, 403), P<0.001]. This difference remained significant after adjustment for the variables listed above (P <0.001).
Conclusion: Patients with PAD have significantly higher NT-pro-BNP levels than control subjects. Within the subset of PAD, those with “stiff” vessels 
have higher levels than those without “stiff” vessels. These findings suggest increased hemodynamic stress in patients with PAD, particularly in the 
subset with “stiff” vessels.
